Researchers focus on reversing the scarring that’s common to liver diseases.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

We’re working to bring the hope of advanced medicine to more patients.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

How much do you know about eyes? Learn more about the fastest muscle in the human body.